by Juliette Boynton | Aug 28, 2024 | UPC
The matter started when Amgen sued various Sanofi companies and Regeneron for patent infringement of their EP3666797 patent. The patent claims an antibody that binds to the catalytic domain of a PCSK9 protein and its use in treating or preventing...
by Sean Hutchinson | Jun 7, 2024 | UPC
When the European Union’s new Unified Patent Court (“UPC”) opened for business in June last year, its jurisdiction only extended to 17 of the 27 EU Member States. A further 7 Member States committed to joining at a later date, with Croatia, Spain, and Poland opting...
by Carolyn Haywood | May 31, 2024 | UPC
On 24th April 2024, in case UPC_CFI_316/2023, the UPC’s Paris Central Division granted Nicoventures Trading Limited access to written pleadings and evidence in a patent revocation case brought by NJOY Netherlands B.V. against Juul Labs International, Inc concerning...
by Sean Hutchinson | Apr 2, 2024 | UPC
The UPC’s rules of procedure provide that when deciding whether to grant a preliminary injunction, the court may require the party applying for the preliminary injunction to show with a “sufficient degree of certainty” that the patent in question is valid and...
by Chloe Sullivan | Sep 14, 2023 | UPC
The application for the issue of an injunction resulted from a dispute between myStromer AG, the proprietor of European Patent No. 2546134, and RevoltZycling AG, the alleged infringer of the European patent in question. The Judge’s reasoning for issuing the...
by Sean Hutchinson | Jun 1, 2023 | EPO, UPC
In 2013, several Member States of the European Union concluded the Agreement on a Unified Patent Court (the “UPC Agreement”). The purpose of that Agreement was to establish a common court for hearing infringement and revocation actions regarding European patents, with...
Recent Comments